Optimization of SELDI for Biomarker Detection in Plasma

Methods in Molecular Biology

Volumn 691, Issue , 2011, Pages 351-368

  Léonard, Jean Francois ^a   Courcol, Martine ^a   Gautier, Jean Charles ^a  

^a SANOFI   (France)

Author keywords

Bias investigation; Quality control; Reference plasma; SELDI

Indexed keywords

BIOLOGICAL MARKER; METAL;

ANIMAL; ARTICLE; BLOOD; BLOOD ANALYSIS; CHEMICAL PHENOMENA; CHEMISTRY; MASS SPECTROMETRY; METHODOLOGY; MULTIVARIATE ANALYSIS; PROTEIN DENATURATION; QUALITY CONTROL; RAT; SPRAGUE DAWLEY RAT; STANDARD; STATISTICS; SURFACE PROPERTY;

ANIMALS; BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; METALS; MULTIVARIATE ANALYSIS; PROTEIN DENATURATION; QUALITY CONTROL; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE STANDARDS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STATISTICS AS TOPIC; SURFACE PROPERTIES;

EID: 79952198907     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-60761-849-2_22     Document Type: Chapter

References (15)

1. Merchant, M., and Weinberger, S.R. (2000) Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis 21, 1164–1167.
2. Adam, B.L, Qu, Y., Davis. J., Ward, M.D., Clements, M.A., Cazares, L.H., Semmes, O.J., Schellhammer, P.F., Yasui, Y., Feng, Z., and Wright, G.L. Jr. (2002). Serum protein finger- printing coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res. 62, 3609–3614.
3. Petricoin, E.F., Ardekani, A.M., Hitt, B.A., Levine, P.J., Fusaro, V.A., Steinberg, S.M., Mills, G.B., Simone, C., Fishman, D.A., Kohn, E.C., and Liotta, L.A. (2002). Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359, 572–577.
4. Ward, D.G., Suggett, N., Cheng, Y., Wei, W., Johnson, H., Billingham, L.J., Ismail, T., Wakelam, M.J., Johnson, P.J., and Martin, A. (2006). Identification of serum biomarkers for colon cancer by proteomic analysis. Br. J. Cancer 94, 1898–1905.
5. Carrette, O., Demalte, I., Scherl,. A, Yalkinoglu, O., Corthals, G., Burkhard, P., Hochstrasser, D.F., and Sanchez, J.C. (2003). A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer’s disease. Proteomics 8, 1486–1494.
6. Florian-Kujawski, M., Hussain, W., Chyna, B., Kahn, S., Hoppensteadt, D., Leya, F., and Fareed, J. (2004). Biomarker profiling of plasma from acute coronary syndrome patients. Application of ProteinChip array analysis. Int. Angiol. 3, 246–254.
7. Wetmore, B.A., and Merrick, B.A. (2004). Toxicoproteomics: proteomics applied to toxicology and pathology. Toxicol. Pathol. 32, 619–642.
8. Dare, T.O., Davies, H.A., Turton, J.A., Lomas, L., Williams, T.C., and York, M.J. (2002). Application of surface-enhanced laser desorption/ionization technology to the detection and identification of urinary parvalbumin-alpha: a biomarker of compound-induced skeletal muscle toxicity in the rat. Electrophoresis 18, 3241–3251.
9. White, C.N., Zhang, Z., and Chan, D.W. (2005). Quality control for SELDI analysis. Clin. Chem. Lab. Med. 43, 125–126.
10. Rodland, K.D. (2004). Proteomics and cancer diagnosis: the potential of mass spectrometry. Clin. Biochem. 7, 579–583.
11. Semmes, O.J., Feng, Z., Adam, B.L., Banez, L.L., Bigbee, W.L., Campos, D., Cazares, L.H., Chan, D.W., Grizzle, W.E., Izbicka, E., Kagan, J., Malik, G., McLerran, D., Moul, J.W., Partin, A., Prasanna, P., Rosenzweig, J., Sokoll, L.J., Srivastava, S., Srivastava, S., Thompson, I., Welsh, M.J., White, N., Winget, M., Yasui, Y., Zhang, Z., and Zhu, L. (2005). Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility. Clin. Chem. 51, 102–112.
12. Coombes, K.R., Fritsche, H.A. Jr., Clarke, C., Chen, J.N., Baggerly, K.A., Morris, J.S., Xiao, L.C., Hung, M.C., and Kuerer, H.M. (2003). Quality control and peak finding for proteomics data collected from nipple aspirate fluid by surface-enhanced laser desorption and ionization. Clin. Chem. 49, 1615–1623.
13. Hong, H., Dragan, Y., Epstein, J., Teitel, C., Chen, B., Xie, Q., Fang, H., Shi, L., Perkins, R., and Tong, W. (2005) Quality control and quality assessment of data from surface-enhanced laser desorption/ionization (SELDI) time-of flight (TOF) mass spectrometry (MS). BMC Bioinformatics 6, Suppl 2:S5.
14. Baggerly, K.A., Morris, J.S., and Coombes, K.R. (2004) Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments. Bioinformatics 20, 777–785.
15. Liggett, W.S., Barker, P.E., Semmes, O.J., and Cazares, L.H. (2004). Measurement reproducibility in the early stages of biomarker development. Dis. Markers 6, 295–307